IL95839A - Quinoline derivatives, the process for their preparation and medicinal preparations containing them - Google Patents
Quinoline derivatives, the process for their preparation and medicinal preparations containing themInfo
- Publication number
- IL95839A IL95839A IL9583990A IL9583990A IL95839A IL 95839 A IL95839 A IL 95839A IL 9583990 A IL9583990 A IL 9583990A IL 9583990 A IL9583990 A IL 9583990A IL 95839 A IL95839 A IL 95839A
- Authority
- IL
- Israel
- Prior art keywords
- dihydro
- oxo
- methyl
- compound
- chlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measurement Of Radiation (AREA)
- Holo Graphy (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26278289 | 1989-10-06 | ||
JP32229089 | 1989-12-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL95839A0 IL95839A0 (en) | 1991-06-30 |
IL95839A true IL95839A (en) | 1995-03-15 |
Family
ID=26545706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9583990A IL95839A (en) | 1989-10-06 | 1990-09-28 | Quinoline derivatives, the process for their preparation and medicinal preparations containing them |
Country Status (17)
Country | Link |
---|---|
US (1) | US5223513A (hr) |
EP (1) | EP0421456B1 (hr) |
KR (1) | KR910007883A (hr) |
CN (1) | CN1050715A (hr) |
AT (1) | ATE116301T1 (hr) |
AU (1) | AU629048B2 (hr) |
CA (1) | CA2026890C (hr) |
DE (1) | DE69015541T2 (hr) |
FI (1) | FI904915A0 (hr) |
HU (1) | HUT55364A (hr) |
IE (1) | IE903454A1 (hr) |
IL (1) | IL95839A (hr) |
NO (1) | NO904300L (hr) |
NZ (1) | NZ235582A (hr) |
PT (1) | PT95515A (hr) |
RU (1) | RU2001910C1 (hr) |
TW (1) | TW205037B (hr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
CA2108014A1 (en) * | 1991-04-26 | 1992-10-27 | Ernest S. Hamanaka | 4-aryl-3-(heteroarylureido)quinoline derivatives |
CA2128093C (en) * | 1992-01-23 | 1998-02-03 | Ernest S. Hamanaka | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
TW241258B (hr) * | 1992-04-15 | 1995-02-21 | Takeda Pharm Industry Co Ltd | |
WO1993024458A1 (en) * | 1992-05-28 | 1993-12-09 | Pfizer Inc. | New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat) |
NO179904C (no) * | 1992-09-04 | 1997-01-08 | Takeda Chemical Industries Ltd | Kondenserte heterocykliske forbindelser og deres anvendelse |
US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
TW263498B (hr) * | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
US6133326A (en) | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
JP2001513560A (ja) * | 1997-08-28 | 2001-09-04 | ブリストル−マイヤーズ スクイブ カンパニー | 4−アリール−3−アミノキノリン−2−オン誘導体カリウムチャンネル調節剤 |
CA2321237A1 (en) | 1998-02-25 | 1999-09-02 | Masami Muraoka | Pyridone derivatives and process for producing the same |
US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
ES2239145T3 (es) | 2000-02-02 | 2005-09-16 | Warner-Lambert Company Llc | Inhibidor doble de la sintesis de ester de colesterilo y de ester de cera avasimibe para el tratamiento de trastornos de la glandula sebacea. |
KR100835031B1 (ko) * | 2001-03-02 | 2008-06-03 | 수미토모 케미칼 컴퍼니 리미티드 | 퀴놀린-3-카르복실산 화합물의 제조방법 |
CA2539760C (en) * | 2003-09-23 | 2011-01-25 | Merck & Co., Inc. | Quinoline potassium channel inhibitors |
CN103906735B (zh) * | 2011-11-04 | 2016-12-07 | 霍夫曼-拉罗奇有限公司 | 新芳基-喹啉衍生物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1216878B (de) * | 1963-04-02 | 1966-05-18 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins |
NO133758C (hr) * | 1970-04-04 | 1976-06-23 | Takeda Chemical Industries Ltd | |
JPS555502B1 (hr) * | 1971-07-31 | 1980-02-07 | ||
US4530931A (en) * | 1983-01-03 | 1985-07-23 | Usv Pharmaceutical Corp. | 8-Quinoline carbanilates for the inhibition of lipolysis |
DE3586445T2 (de) * | 1984-06-26 | 1993-01-14 | Merck & Co Inc | Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen. |
IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
-
1990
- 1990-09-20 TW TW079107912A patent/TW205037B/zh active
- 1990-09-25 IE IE345490A patent/IE903454A1/en unknown
- 1990-09-25 US US07/587,795 patent/US5223513A/en not_active Expired - Fee Related
- 1990-09-28 IL IL9583990A patent/IL95839A/en not_active IP Right Cessation
- 1990-09-28 AU AU63707/90A patent/AU629048B2/en not_active Ceased
- 1990-10-03 NO NO90904300A patent/NO904300L/no unknown
- 1990-10-04 PT PT95515A patent/PT95515A/pt not_active Application Discontinuation
- 1990-10-04 CA CA002026890A patent/CA2026890C/en not_active Expired - Fee Related
- 1990-10-05 EP EP90119128A patent/EP0421456B1/en not_active Expired - Lifetime
- 1990-10-05 DE DE69015541T patent/DE69015541T2/de not_active Expired - Fee Related
- 1990-10-05 NZ NZ235582A patent/NZ235582A/en unknown
- 1990-10-05 HU HU906360A patent/HUT55364A/hu unknown
- 1990-10-05 CN CN90108222A patent/CN1050715A/zh active Pending
- 1990-10-05 AT AT90119128T patent/ATE116301T1/de not_active IP Right Cessation
- 1990-10-05 RU SU904831426A patent/RU2001910C1/ru active
- 1990-10-05 FI FI904915A patent/FI904915A0/fi not_active Application Discontinuation
- 1990-10-06 KR KR1019900015908A patent/KR910007883A/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69015541T2 (de) | 1995-06-01 |
CA2026890A1 (en) | 1991-04-07 |
PT95515A (pt) | 1991-08-14 |
KR910007883A (ko) | 1991-05-30 |
JPH03223254A (ja) | 1991-10-02 |
CN1050715A (zh) | 1991-04-17 |
NO904300D0 (no) | 1990-10-03 |
RU2001910C1 (ru) | 1993-10-30 |
AU6370790A (en) | 1991-04-11 |
EP0421456A3 (en) | 1991-05-29 |
HUT55364A (en) | 1991-05-28 |
FI904915A0 (fi) | 1990-10-05 |
IE903454A1 (en) | 1991-04-10 |
DE69015541D1 (de) | 1995-02-09 |
EP0421456B1 (en) | 1994-12-28 |
CA2026890C (en) | 2001-09-18 |
HU906360D0 (en) | 1991-04-29 |
ATE116301T1 (de) | 1995-01-15 |
NZ235582A (en) | 1992-03-26 |
AU629048B2 (en) | 1992-09-24 |
EP0421456A2 (en) | 1991-04-10 |
US5223513A (en) | 1993-06-29 |
IL95839A0 (en) | 1991-06-30 |
TW205037B (hr) | 1993-05-01 |
NO904300L (no) | 1991-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2026890C (en) | Quinoline derivatives, their production and use | |
EP0354994B1 (en) | Quinoline derivatives, their production and use | |
US3702849A (en) | 4-(isoquinolin-1-yl) piperazine-1-carboxylic acid esters | |
US5700810A (en) | Condensed heterocyclic compounds, their production and use | |
NO171785B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater | |
CA2071224C (en) | Quinoline derivatives, their production and use | |
NO794135L (no) | Substituerte 4(3h)-kinazolinoner, fremgangsmaate ved fremstilling og anvendelse av disse | |
EP0481383B1 (en) | Heterocyclic amine derivatives, their production and use | |
US5278186A (en) | Chromene derivatives, their production and use | |
US5264454A (en) | Certain 2-oxo-tetrahydro-cycloalkyl-benzopyran-3yl ureas having acyl-CoA-cholesterol acyl transferase inhibitory activity | |
JPH0710844A (ja) | 縮合複素環化合物、その製造法および剤 | |
HINO et al. | Synthesis and pharmacological activities of 3-phenyl-2-(1-piperazinyl) quinolines and related compounds | |
IE51542B1 (en) | Therapeutic agents | |
RU1838301C (ru) | Способ получени производного хинолина или его соли | |
GB2085441A (en) | Therapeutic agents | |
JP3004041B2 (ja) | キノリン誘導体、その製法および用途 | |
JPH0753714B2 (ja) | Acat阻害剤、キノリン誘導体及びその製造法 | |
EP0126342A2 (en) | 3-Alkyl-8-chloro-5,6-dihydrofuro-[3,2-f]-1,2-benzisoxazole-6-carboxylic acids | |
KR820000099B1 (ko) | 피리도[2, 1-b] 퀴나졸린 유도체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |